PROCEPT BioRobotics (PRCT) Insider Trades, Congress & Funds

Smart money at a glance

Filings to Oct 31, 2026

Net buying: insiders sold $22K and bought $498K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: +$476K netNet buying
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, quarter ended Jun 30, 2026: 0 added, 1 cutMore cutting

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about PRCT filings

Are insiders buying or selling Procept Biorobotics Corp (PRCT) stock?

Net buying: insiders sold $22K and bought $498K of PRCT stock on the open market in the 90 days to Oct 31, 2026, according to SEC Form 4 filings. The largest was Wood, Larry L (President, CEO), who bought $498K. The latest filing was on Sep 10, 2026.

Which members of Congress have traded PRCT recently?

None. No member of Congress disclosed a PRCT trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this PRCT smart-money data?

This summary uses filings available on Oct 31, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

13F: filed up to 45 days late.

Smart money on PRCT

Lean short2 sources:
- Insiders
- Funds

Top traders
No tracked positions at the last update
Insiders
Lean short3 sales · $21.9K
Form 4 filings, open market.
Politicians
No recent politician filings found
Funds
Lean short1 added · 2 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about PRCT filings

Are insiders buying or selling Procept Biorobotics Corp (PRCT) stock?

Which members of Congress have traded PRCT recently?

None. No member of Congress disclosed a PRCT trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this PRCT smart-money data?

Funds

What funds are doing

4 moves · 6 mo

Buys/Adds$41.3MSells/Trims$138.0M

Buys/Adds (1)

P7
Point72
Steven Cohen · Q1 2026 13F
$28.2M
bought
Signals like this: n=3224, 54% finished lower at D15, median -0.8% vs SPY -0.4%

Sells/Trims (2)

P7
Point72
Steven Cohen · Q2 2026 13F
$28.2M
sold
Signals like this: n=2234, 53% finished lower at D15, median -0.5% vs SPY -0.4%
FM
FMR LLC
Q1 2026 13F
$109.8M
trimmed
Signals like this: n=7469, 53% finished lower at D15, median -0.5% vs SPY -0.4%

1 more moves

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 1 moves

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 4, 2026

Earnings came in 3.7% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 4, 2026

Period ending

Jun 30, 2026

Earnings per share

-$0.47-3.69% miss

-$0.45 expected

Revenue

$94.5M

SEC filing

EPS: Yahoo Finance

Next report

Estimated report: Nov 3, 2026, in 3 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Aug 4, 2026	-$0.47est. -$0.45	-3.69%miss	$94.5MSEC filing	+19.3%from $79.2M
Mar 31, 2026Reported Apr 29, 2026	-$0.56est. -$0.56	+0.88%in line	$83.1MSEC filing	+20.2%from $69.2M
Dec 31, 2025Reported Feb 25, 2026	-$0.53est. -$0.32	-64.10%miss	$76.4MYahoo Finance	No year-ago quarter
Sep 30, 2025Reported Nov 4, 2025	-$0.38est. -$0.42	+9.76%beat	$83.3MSEC filing	+42.8%from $58.4M
Jun 30, 2025Reported Aug 6, 2025	-$0.35est. -$0.41	+14.63%beat	$79.2MSEC filing	+48.4%from $53.4M
Mar 31, 2025Reported Apr 24, 2025	-$0.45est. -$0.49	+8.16%beat	$69.2MSEC filing	+55.3%from $44.5M
Dec 31, 2024Reported Feb 25, 2025	-$0.35est. -$0.34	-2.94%miss	$224.5M · FYSEC filing	No year-ago quarter
Sep 30, 2024Reported Oct 28, 2024	-$0.40est. -$0.49	+18.37%beat	$58.4MSEC filing	+66.3%from $35.1M

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $20.33
52-wk high: $38.11
High: $20.37
52-wk low: $16.66
Low: $18.90
Prev close: $20.30
Mkt cap: $1.16B
ROE: -30.2%
Beta: 0.92
P/S: 3.4x
P/B: 3.4x
Profit margin: -32.5%
Op margin: -32.1%

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -32.5%
Market cap: $1.2B

Valuation

P/S3.42
P/B3.40

Quality

Operating margin-32.1%
ROE-30.2%
ROA-14.7%

Growth

Beta0.92

Technicals

Price structure

This stock's price action is mixed.

Trend

Mixed

55 / 100

RSI 14

48balanced

20D volatility

65%annualized

52-week range

$19.20

$16.66$38.11

20D support

$17.13recent floor

20D resistance

$20.67recent ceiling

Returns

5D -3.8%20D +11.9%60D -4.1%

Price vs moving averages

SMA20 +2.1%SMA50 -1.0%SMA200 -17.7%

Volume pace

0.76xvs prior 20D

Smart money at a glance

Filings to Oct 31, 2026

Net buying: insiders sold $22K and bought $498K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: +$476K netNet buying
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, quarter ended Jun 30, 2026: 0 added, 1 cutMore cutting

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about PRCT filings

Are insiders buying or selling Procept Biorobotics Corp (PRCT) stock?

Which members of Congress have traded PRCT recently?

None. No member of Congress disclosed a PRCT trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this PRCT smart-money data?

13F: filed up to 45 days late.

Smart money on PRCT

Lean short2 sources:
- Insiders
- Funds

Top traders
No tracked positions at the last update
Insiders
Lean short3 sales · $21.9K
Form 4 filings, open market.
Politicians
No recent politician filings found
Funds
Lean short1 added · 2 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about PRCT filings

Are insiders buying or selling Procept Biorobotics Corp (PRCT) stock?

Which members of Congress have traded PRCT recently?

None. No member of Congress disclosed a PRCT trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this PRCT smart-money data?

Funds

What funds are doing

4 moves · 6 mo

Buys/Adds$41.3MSells/Trims$138.0M

Buys/Adds (1)

P7
Point72
Steven Cohen · Q1 2026 13F
$28.2M
bought
Signals like this: n=3224, 54% finished lower at D15, median -0.8% vs SPY -0.4%

Sells/Trims (2)

P7
Point72
Steven Cohen · Q2 2026 13F
$28.2M
sold
Signals like this: n=2234, 53% finished lower at D15, median -0.5% vs SPY -0.4%
FM
FMR LLC
Q1 2026 13F
$109.8M
trimmed
Signals like this: n=7469, 53% finished lower at D15, median -0.5% vs SPY -0.4%

1 more moves

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 1 moves

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 4, 2026

Earnings came in 3.7% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 4, 2026

Period ending

Jun 30, 2026

Earnings per share

-$0.47-3.69% miss

-$0.45 expected

Revenue

$94.5M

SEC filing

EPS: Yahoo Finance

Next report

Estimated report: Nov 3, 2026, in 3 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Aug 4, 2026	-$0.47est. -$0.45	-3.69%miss	$94.5MSEC filing	+19.3%from $79.2M
Mar 31, 2026Reported Apr 29, 2026	-$0.56est. -$0.56	+0.88%in line	$83.1MSEC filing	+20.2%from $69.2M
Dec 31, 2025Reported Feb 25, 2026	-$0.53est. -$0.32	-64.10%miss	$76.4MYahoo Finance	No year-ago quarter
Sep 30, 2025Reported Nov 4, 2025	-$0.38est. -$0.42	+9.76%beat	$83.3MSEC filing	+42.8%from $58.4M
Jun 30, 2025Reported Aug 6, 2025	-$0.35est. -$0.41	+14.63%beat	$79.2MSEC filing	+48.4%from $53.4M
Mar 31, 2025Reported Apr 24, 2025	-$0.45est. -$0.49	+8.16%beat	$69.2MSEC filing	+55.3%from $44.5M
Dec 31, 2024Reported Feb 25, 2025	-$0.35est. -$0.34	-2.94%miss	$224.5M · FYSEC filing	No year-ago quarter
Sep 30, 2024Reported Oct 28, 2024	-$0.40est. -$0.49	+18.37%beat	$58.4MSEC filing	+66.3%from $35.1M

Open: $20.33
52-wk high: $38.11
High: $20.37
52-wk low: $16.66
Low: $18.90
Prev close: $20.30
Mkt cap: $1.16B
ROE: -30.2%
Beta: 0.92
P/S: 3.4x
P/B: 3.4x
Profit margin: -32.5%
Op margin: -32.1%

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -32.5%
Market cap: $1.2B

Valuation

P/S3.42
P/B3.40

Quality

Operating margin-32.1%
ROE-30.2%
ROA-14.7%

Growth

Beta0.92

Technicals

Price structure

This stock's price action is mixed.

Trend

Mixed

55 / 100

RSI 14

48balanced

20D volatility

65%annualized

52-week range

$19.20

$16.66$38.11

20D support

$17.13recent floor

20D resistance

$20.67recent ceiling

Returns

5D -3.8%20D +11.9%60D -4.1%

Price vs moving averages

SMA20 +2.1%SMA50 -1.0%SMA200 -17.7%

Volume pace

0.76xvs prior 20D

Procept Biorobotics Corp

Smart money at a glance

What do analysts expect?

Questions about PRCT filings

Smart money on PRCT

Questions about PRCT filings

What funds are doing

What insiders are doing

What fin-fluencers are saying

How top traders are positioned

Unlock everything for $29/month

Earnings came in 3.7% below what analysts expected.

Estimated report: Nov 3, 2026, in 3 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Procept Biorobotics Corp

Smart money at a glance

What do analysts expect?

Questions about PRCT filings

Smart money on PRCT

Questions about PRCT filings

What funds are doing

What insiders are doing

What fin-fluencers are saying

How top traders are positioned

Unlock everything for $29/month

Earnings came in 3.7% below what analysts expected.

Estimated report: Nov 3, 2026, in 3 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Procept Biorobotics Corp

Overview

Questions about PRCT filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Procept Biorobotics Corp

Overview

Questions about PRCT filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.